Henry ScheinHSIC
Recorded

Henry Schein 2026 Q3 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ3 2026Duration1 hr 3 minParticipants19

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Operator

Good morning, ladies and gentlemen, and welcome to Henry Schein's third quarter 2026 earnings conference call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. Please press the star key followed by 1 on your touch-tone phone if you'd like to ask a question at the end of the call. If anyone should require assistance during the call, please press the star key followed by 0 on your touch-tone phone. As a reminder, this call is being recorded. I would now like to introduce your host for today's call, Graham Stanley, Henry Schein's Vice President of Investor Relations and Strategic Financial Project Officer.

Graham StanleyVP of Investor Relations and Strategic Financial Project Officer

Please go ahead, Graham. Thank you, operator, and thanks to everyone for joining us this morning to discuss Henry Schein's financial results for the third quarter.

Graham StanleyVP of Investor Relations and Strategic Financial Project Officer

With me on today's call are Fred Lowery, Chief Executive Officer, Ron South, Senior Vice President and Chief Financial Officer, and Emmanuel Caprais, who will succeed Ron as Chief Financial Officer effective tomorrow, November 4th. Before we begin, I'd like to state that certain comments made during this call will include information that is forward-looking. Risks and uncertainties involved in the company's business may affect the matters referred to in forward-looking statements, and the company's performance may materially differ from those expressed in or indicated by such statements. These forward-looking statements are qualified in their entirety by the cautionary statements contained in Henry Schein's filings with the Securities and Exchange Commission and included in the risk factors section of those filings.

Graham StanleyVP of Investor Relations and Strategic Financial Project Officer

In addition, all comments about the markets we serve, including end market growth rates and market share, are based upon the company's internal analyses and estimates. Today's remarks will include both GAAP and non-GAAP financial results. We believe the non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable the comparison of financial results between periods where certain items may vary independently of business performance, and allow for greater transparency with respect to key metrics used by management in operating our business. These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding GAAP measures.

Graham StanleyVP of Investor Relations and Strategic Financial Project Officer

Reconciliations between GAAP and non-GAAP measures are included in the exhibits of today's press release and can be found in the financials and filings section of our investor relations website under the supplemental information heading, and in our quarterly earnings presentation also posted on our investor relations website. The contents of this conference call contains time-sensitive information that is accurate only as of the date of the live broadcast, November 1st, 2026. Henry Schein undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this call. Lastly, during today's Q&A session, please limit yourself to a single question so that we can accommodate questions from as many of you as possible. With that, I'd like to turn the call over to Fred Lowery.

Fred LoweryCEO

Thank you, Graham, and good morning, everyone. Before turning to our results, I would like to welcome Emmanuel Caprais, who will become Henry Schein's Chief Financial Officer effective November 4. We are really excited to have you on the team. I would also like to recognize Ron, who has played instrumental roles at Henry Schein over nearly two decades, including the past four years as CFO. Ron has demonstrated authentic leadership and disciplined stewardship throughout his tenure, and his contributions have built a solid foundation for our future. He will be staying on as a senior advisor, working closely with Emmanuel to ensure a smooth transition. Ron, thank you again for your leadership and your tremendous contributions to Henry Schein. On a personal note, I would say a big thank you for how you have helped me on board into the company.

Fred LoweryCEO

Now, before we move to results, Emmanuel, would you like to say a few words?

Emmanuel CapraisCFO

Thank you, Fred. I am very pleased to join Henry Schein and excited about the meaningful opportunities ahead to drive growth, expand margins, and create long-term shareholder value. I greatly appreciate the warm welcome I have received from Team Schein members over the last few weeks, and I value the opportunity to begin engaging with colleagues across the organization. I look forward to partnering with Fred, the leadership team, and Team Schein members, and I want to thank Ron for his support throughout the transition. I also look forward to engaging with many of you in the investment community.

Fred LoweryCEO

Thank you, Emmanuel. Now turning to our results. We delivered another strong quarter that increases our confidence in the momentum we are building at Henry Schein. We are gaining share, expanding margins, and delivering strong underlying earnings growth. Here are a few highlights from the quarter. U.S. dental merchandise sales grew 8.6%, including 7% internal local currency growth, driven primarily by volume in a stable market. Excluding the net benefit from tariff refunds this quarter and the prior year remeasurement gain, adjusted non-GAAP diluted EPS increased 19.1% to $1.37. We expanded non-GAAP operating margin by 20 basis points in the quarter, and we repurchased $125 million of Henry Schein stock, bringing the year-to-date repurchases to $450 million and reflecting our disciplined approach to capital allocation.

Fred LoweryCEO

I'm very pleased with the U.S. dental merchandise sales growth of 8.6%, driven primarily by volume in a stable market, and the 19% adjusted earnings per share growth. It shows that we're winning new customers, expanding our share of wallet, and growing our company-owned and exclusive products, and executing effectively through our sales organizations. At the same time, we're seeing growing financial benefits from our value creation initiatives. Our commitments have not changed, and we continue to expect more than $200 million of operating income improvement, including $125 million run rate by the end of 2026. Together, with a more attractive business mix and greater operating discipline, these initiatives are helping us convert growth into stronger earnings performance.

Fred LoweryCEO

We are therefore raising our financial guidance for the year, reflecting the net benefit of tariff refunds received during the quarter, targeted and limited growth investments in the fourth quarter, which will contribute to growth in 2027, and improved underlying business performance. My initial priorities coming into the role were clear: execute against our 2026 financial plan, deliver our value creation commitments, and invest selectively to accelerate growth. We're making strong progress. Our agenda remains focused on accelerating growth, simplifying the business, and bringing greater rigor and discipline to execution. Let's start first with accelerating growth. We continue to invest in those areas where we see the greatest opportunities to gain share and deepen our customer relationships. The results we're seeing have increased our confidence in several growth initiatives.

Fred LoweryCEO

We have therefore made the deliberate decision to make some limited incremental investments in the fourth quarter, focused on winning new customers, increasing our share of wallet, and converting more episodic customers into long-term Henry Schein customers. Our objective is to build on the share gains that we're already achieving. New product development is an important part of our growth expectations, particularly across company-owned products and practice management software. For example, our recently launched Versalis implant positions us well in the fast-growing value implant category. More suppliers are also choosing to offer exclusive products and promotions through our distribution channel, underscoring the differentiated value of the Henry Schein platform. Our investments in Henry Schein One, which is our market-leading technology business, continue to drive accelerated growth in our cloud-based practice management platforms as we embed AI-enabled capabilities that improve workflows, improve collections, patient engagement, and overall practice performance.

Fred LoweryCEO

These capabilities help dental practices by identifying revenue opportunities, automating administrative work, and improving clinical and operational workflows. This is particularly valuable as practices manage labor constraints and rising operating costs. In our medical business, we remain focused on attractive areas of growth, including our Home Solutions business, where we delivered double-digit growth in the quarter. Our second priority is simplifying the business. We are reducing organizational complexity, getting closer to the operations, and speeding up decision-making. We have continued to delayer the organization, establish our executive team, and align decision-making more closely with our operating businesses. By advancing shared services, centralizing selected activities, and driving greater collaboration, we're making it easier for our customers to work with us. We are outsourcing selected functions, advancing shared services, centralizing indirect procurement, and building stronger pricing and margin management capabilities.

Fred LoweryCEO

Our focus is ensuring that our operating income improvements we've committed to deliver are realized in the P&L, and that they build over time. Additional initiatives are being prioritized based on impact and return, including further portfolio streamlining, shared services, and outsourcing, AI capabilities, and supply chain tools designed to improve efficiency, reduce inventory, and simplify processes. Simplification should make us faster, more consistent, and more effective at converting top-line growth into bottom-line growth. Our third priority is bringing greater rigor and discipline to our execution. This includes prioritizing investments and resources toward those areas with the greatest potential to drive sustainable growth and returns. It also applies to capital allocation, where we're taking a disciplined approach that balances investments with returning capital to shareholders. This discipline is particularly important in an environment that can change quickly.

Fred LoweryCEO

Like most businesses, we're experiencing inflation in our cost of goods sold, which we are successfully offsetting through productivity initiatives, strategic pricing, and lower-priced equivalent products, including our company-owned brands. Our customers increasingly need an integrated partner that can simplify practice management, and we are uniquely positioned to deliver that breadth of solution at scale. Now, let me turn to our business performance and what we're seeing in the market. As I mentioned earlier, we achieved excellent growth in our U.S. dental merchandise sales in the third quarter, with 8.6% total sales growth, 7% local currency internal growth. Importantly, it was driven primarily by volume rather than price, and particularly among private practices and emerging DSOs. We believe this reflects continued market share gains from our own brand portfolio and from exclusive products such as Curodont.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

Other earnings calls that day

View calls from this day